ConvergEx expands EZE OMS

First Published 3rd November 2011

Eze Risk Framework offers products from Investor Analytics, FinAnalytica, PortfolioScience and Risk One

ConvergEx Group has announced that its order management system, the Eze OMS, has expanded the number of integrated risk management tools available through the Eze Risk Framework.

The Framework, which gives users direct access to third-party risk providers, now offers products from Investor Analytics, FinAnalytica, PortfolioScience and Risk One. Available risk management tools include end-of-day reporting, Value at Risk (VaR) statistics, scenario and what-if analysis and intra-day statistics. Users will also be able to combine risk analysis with stress testing and scenario analysis for a tactical and strategic approach to risk management. These tools are in addition to existing Framework offerings from RiskMetrics.

"Actively managing risk in a variety of ways is a necessity in these volatile markets. Investors are under increasing pressure from clients and regulators to provide reports about risk in their portfolio, but finding streamlined and integrated solutions have until now been difficult," said Davide Cis, risk product manager for ConvergEx's Eze Castle Software. "We are pleased to form these relationships because they give our customers cost-effective and comprehensive risk solutions that are straightforward and easy to use. Furthermore, these providers are experienced and knowledgeable, with excellent reputations for client service."

"Working with ConvergEx was a natural choice since so many of our customers have chosen the Eze OMS as their preferred technology," said Michael Poisson, chief sales and marketing officer of Investor Analytics. "Customers want solutions that are powerful yet intuitive, and both Eze and Investor Analytics have always offered customers a considerable degree of choice and ease to implement the changes they want."

  • Copyright © Automated Trader Ltd 2014 - The Gateway to Algorithmic and Automated Trading

click here to return to the top of the page